From the Editor-In-Chief
The U.S. health care system must adapt to the needs of cancer survivors.
by William G. Nelson, MD, PhD
A Matter of Age | Alternatives to Opioids | Treating Head and Neck Skin Cancers | In Women, Lung Cancer Rates Are Rising Worldwide | Breaking Down Breakthrough Cancer Therapies | The Devastating Impact of Muscle Wasting | What’s Next?
Your Cancer Guide
Deciding when and what to worry about can help with gaining control over fear.
by Hester Hill Schnipper
Caregiving with Confidence
Healthy sleep habits should be an important part of self-care for caregivers.
by Aimee Swartz
Let your voice be heard in support of robust, sustained and predictable federal funding increases.
by George D. Demetri, MD
Breast cancer survivor Bob Riter forges connections among people affected by all types of cancer.
by Marci A. Landsmann
New tools are being integrated into the research process to ease patients’ access to clinical trials and improve their experience.
by Bradley Jones
Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.
by Kate Yandell
Cancer and its treatment can hinder sexual intimacy, but help is available. Talking about the problem is the first step.
by Cameron Walker
Carb Connection | Make Your Move
Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.
Experts offer advice on accompanying a friend to a doctor’s appointment, responding to a no evidence of disease diagnosis, and sharing the results of genetic testing.
The End of Treatment Bells fundraiser helps patients mark milestones.
by Sophy Ziss
Readers share snapshots of their lives today.
People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
Patients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Authors make a call for anti-racist cancer research.
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
Learning Medicare’s ABCDs
donate to the AACR